PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 18, 2026PharmacoEconomics - Open0 citationsOpen Access

Updated Health Economics Simulation Model of the Lifetime Progression of Multiple Sclerosis in an Australian Setting

APAndrew J. PalmerTZTing ZhaoGHGlen Henson

Key Points

  • The research aims to enhance the health economics simulation model to evaluate multiple sclerosis (MS) progression and interventions.
  • Incorporated a larger cohort for improved data reflectiveness.
  • Updated inputs related to disease progression and economic factors.
  • Enhanced face validity of the simulation model.
  • The model offers a clearer assessment of MS's impact on life expectancy.
  • Higher accuracy in estimating quality-adjusted life years (QALYs) for MS patients.
  • Facilitates more reliable cost-effectiveness analyses of MS interventions.

Abstract

Our improved model, based on a larger cohort and updated inputs, provides a more nuanced assessment of the impact of MS on LE, QALYs, and costs, with improved face validity. It will be used for the cost-effectiveness analyses of current and future MS interventions.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Palmer et al. (2026) studied this question.

synapsesocial.com/papers/69e31f7340886becb653ea3dhttps://doi.org/10.1007/s41669-026-00650-1
Ask AI
Helpful
Bookmark
Share
View Full Paper